Tamoxifen evolution

A Howell; S J Howell

doi:10.1038/s41416-023-02158-5

Tamoxifen evolution

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	421-425
Number of pages	5
Journal	British Journal of Cancer
Volume	128
Issue number	3
DOIs	https://doi.org/10.1038/s41416-023-02158-5
Publication status	Published - 10 Feb 2023

Keywords

Humans
Female
Tamoxifen/therapeutic use
Antineoplastic Agents, Hormonal/therapeutic use
Breast Neoplasms/drug therapy

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41416-023-02158-5Licence: CC BY

Cite this

@article{f5f7d83efef1451580adba08217de6eb,

title = "Tamoxifen evolution",

keywords = "Humans, Female, Tamoxifen/therapeutic use, Antineoplastic Agents, Hormonal/therapeutic use, Breast Neoplasms/drug therapy",

author = "A Howell and Howell, {S J}",

year = "2023",

month = feb,

day = "10",

doi = "10.1038/s41416-023-02158-5",

language = "English",

volume = "128",

pages = "421--425",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

number = "3",

}

TY - JOUR

T1 - Tamoxifen evolution

AU - Howell, A

AU - Howell, S J

PY - 2023/2/10

Y1 - 2023/2/10

KW - Humans

KW - Female

KW - Tamoxifen/therapeutic use

KW - Antineoplastic Agents, Hormonal/therapeutic use

KW - Breast Neoplasms/drug therapy

U2 - 10.1038/s41416-023-02158-5

DO - 10.1038/s41416-023-02158-5

M3 - Review article

C2 - 36765172

SN - 0007-0920

VL - 128

SP - 421

EP - 425

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 3

ER -